We overexpressed the MANF protein in the peri-infarct area 2 days after dMCAo by intracerebral AAV7-MANF injection and found improved neurological function already on day 4 and up to day 14 post-stroke (Matlik et al., 2018). This evidence concerns the gene MANF and stroke disorder.